Electronic Cigarettes: A Policy Statement From the American Heart Association

  title={Electronic Cigarettes: A Policy Statement From the American Heart Association},
  author={Aruni Bhatnagar and Laurie Whitsel and Kurt M. Ribisl and Chris Bullen and Frank J Chaloupka and Mariann R. Piano and Rose Marie Robertson and Timothy R. McAuley and David Calvin Goff and Neal L. Benowitz},
For decades, advocacy for tobacco control has been a priority of the American Heart Association (AHA). In partnership with major public health organizations, the association has made major strides in tobacco use prevention and cessation by prioritizing evidence-based strategies such as increasing excise taxes; passing comprehensive smoke-free air laws; facilitating US Food and Drug Administration (FDA) authority to regulate tobacco, including comprehensive tobacco cessation treatment within… 

Tables from this paper

Public Health Policies on E-Cigarettes
E-cigarettes can be a tool for smoking cessation for current smokers and several studies have reported that e-cigarettes significantly reduce an existing smoker’s risk of being exposed to toxic tobacco smoke constituents that are normally present in cigarette smoke.
Electronic nicotine delivery systems: executive summary of a policy position paper from the American College of Physicians.
This paper is not intended to offer clinical guidance or serve as an exhaustive literature review of existing ENDS-related evidence but to help direct the College, policymakers, and regulators on how to address these products.
Prevalence and Distribution of E-Cigarette Use Among U.S. Adults: Behavioral Risk Factor Surveillance System, 2016
The most up-to-date national and state-level prevalence of current e-cigarette use among U.S. adults was determined using the largest and most extensive dynamic health survey, the 2016 Behavioral Risk Factor Surveillance System (BRFSS), to help inform the work of researchers, public health officials, and regulatory authorities seeking to understand current trends in e-cigarettes.
Reducing tobacco use among women of childbearing age: Contributions of tobacco regulatory science and tobacco control.
  • A. Kurti
  • Medicine, Political Science
    Experimental and clinical psychopharmacology
  • 2019
Examining contributions to reducing tobacco use among women of childbearing age spanning the domains of tobacco regulatory science and tobacco control from the passage of the Family Smoking Prevention and Tobacco Control Act in 2009 through September 2019 finds existing obstacles must be surmounted to continue reducing Tobacco use and protecting health among this population.
New and Emerging Tobacco Products and the Nicotine Endgame: The Role of Robust Regulation and Comprehensive Tobacco Control and Prevention A Presidential Advisory From the American Heart Association
There is urgent need for robust US Food and Drug Administration regulation of all tobacco products to avoid the significant economic and population health consequences of continued tobacco use.
Use of Electronic Nicotine Delivery Systems Among Adolescents: Status of the Evidence and Public Health Recommendations.
The advantages and disadvantages of using ENDS espoused in these position statements, especially as they relate to use among adolescents are summarized.
Smoke screen: The teen vaping epidemic uncovers a new concerning addiction.
Concerns related to e-cigarette use in the adolescent population and the important role NPs can play in promoting their health and well-being are addressed.
The Economics of Tobacco Regulation: A Comprehensive Review
Tobacco regulation has been a major component of health policy in the developed world since the UK’s Royal College of Physicians’ and the U.S. Surgeon General’s reports in the 1960s. Such regulation,


Ending the tobacco problem : a blueprint for the nation
Ending the Tobacco Problem generates a blueprint for the nation in the struggle to reduce tobacco use, and offers broad-reaching recommendations targeting federal, state, local, nonprofit and for-profit entities.
Impact of Smokeless Tobacco Products on Cardiovascular Disease: Implications for Policy, Prevention, and Treatment: A Policy Statement From the American Heart Association
Clinicians should continue to discourage use of all tobacco products and emphasize prevention of smoking initiation and smoking cessation as primary goals for tobacco control.
Use of e-cigarettes by individuals with mental health conditions
Smokers with MHC are differentially affected by the rise in popularity of e-cigarettes and clinical interventions and policies for tobacco control on e-cigarette should take into account the possible outcomes and their implications for this priority population.
Adult tobacco survey - 19 States, 2003-2007.
These data indicate that respondents support certain state tobacco control measures; for example, the majority of adults in participating states were supportive of smoke-free policies as well as of an increase in tobacco excise tax.
The potential and peril of health insurance tobacco surcharge programs: evidence from Georgia's State Employees' Health Benefit Plan.
These surcharges appear to be effective, but the value of these results, and the effectiveness of health insurance surcharges in changing behavior, are tempered by the important limitation that enrollees' certification of quitting was self-reported and not subject to additional, clinical verification.
A baseline understanding of state laws governing e-cigarettes
In the current absence of federal law governing e-cigarettes, more than one-half of the states have taken the initiative to regulate these products, and the opportunity exists for the remaining states to incorporate e-cigarette-related restrictions into their pre-existing tobacco control laws.
Treating tobacco use and dependence: an evidence-based clinical practice guideline for tobacco cessation.
This article summarizes the major findings and clinical recommendations of the US Department of Health and Human Services/Public Health Service Guideline, Treating Tobacco Use and Dependence, which is a comprehensive, evidence-based blueprint for smoking cessation.
Nicotine control: E-cigarettes, smoking and addiction.